Details

---

Product characteristics:

• The risk of medical staff is small, reducing the probability of droplet infection.
• It's fast and takes only 10 minutes to produces results.
• No special testing environment and personnel training is required.
• Compared with nucleic acid test swabs and pharyngeal swabs, it is less affected by samples and has high accuracy.
• Dosage is less, only 1 drop of serum or plasma sample is needed.
• Testing IgM and IgG at the same time to reduce the testing time.
• Convenient, fast, suitable for mass screening.

When the human body is infected with the 2019-nCoV, the first antibody produced is the specific Igm antibody, which is generally produced after 3-7days of infection, and is replaced by a large number of specific IgG antibodies produced about two weeks later. Therefore, IgM and IgG of the 2019-nCoV specific antibodies can be used as an auxiliary means for the diagnosis of suspected patients.(Not Available in the U.S)

Models: